BiotechTube
Home/Pipeline/Natural Product Collaboration

Natural Product Collaboration

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
Crystec Pharma

About Crystec Pharma

Crystec Pharma is a private, platform technology company leveraging its proprietary mSAS® (modified Supercritical Anti-Solvent) process to engineer drug particles with high precision. The technology aims to solve key pharmaceutical challenges like poor solubility and stability, offering services to partners for drug reformulation and development. While likely pre-revenue or in early revenue from collaborations, its value proposition centers on de-risking and accelerating drug development programs for clients through its AI-enabled screening tool and scalable manufacturing platform.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch
Lighthouse Pilot ProductCipheromePilot
Nitric Oxide + Collagen DeliveryJellagenResearch
UndisclosedAutheraPre-clinical
mRNA Therapeutics Platform ApplicationLupagenResearch
PHYRAGOHanda PharmaceuticalsApproved
TASCENSO ODTHanda PharmaceuticalsApproved
AxulinHousey Pharmaceutical Research LaboratoriesCommercial
PBI-04711Phoenix BiotechnologyPre-clinical
Immunology ProgramIgnite BiomedicalDiscovery